Exalenz Bioscience Ltd (EXEN) - Financial and Strategic SWOT Analysis Review

August 2020 | 32 pages | ID: E064E305D85EN
GlobalData

Abstracts

Exalenz Bioscience Ltd (EXEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Exalenz Bioscience Ltd (Exalenz) carries out the development and commercialization of advanced medical systems for a range of gastrointestinal (GI) tract and liver disorders. The company harnesses its BreathID technology platform for assessment and monitoring of functional disorders. Its flagship product, BreathID Hp is a US FDA approved and European CE marked urea breath test for diagnosing, monitoring and managing gastric Helicobacter pylori (H. pylori) infection in adults as well as pediatric and tests patients of 3 to 17 years of age. It offers BreathID Gastro used for the diagnosis of liver and GI disorders. It also offers BreathID 13C-methacetin breath test, a non-invasive point of care tool measures the microsomal function of the liver. Exalenz is headquartered in Modiin, Israel.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Exalenz Bioscience Ltd - Key Facts
Exalenz Bioscience Ltd - Key Employees
Exalenz Bioscience Ltd - Key Employee Biographies
Exalenz Bioscience Ltd - Major Products and Services
Exalenz Bioscience Ltd - History
Exalenz Bioscience Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Exalenz Bioscience Ltd - Business Description
Exalenz Bioscience Ltd - SWOT Analysis
SWOT Analysis - Overview
Exalenz Bioscience Ltd - Strengths
Exalenz Bioscience Ltd - Weaknesses
Exalenz Bioscience Ltd - Opportunities
Exalenz Bioscience Ltd - Threats
Exalenz Bioscience Ltd - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Exalenz Bioscience Ltd, Medical Equipment, Deals By Year, 2014 to YTD 2020
Exalenz Bioscience Ltd, Medical Equipment, Deals By Type, 2014 to YTD 2020
Exalenz Bioscience Ltd, Recent Deals Summary

SECTION 5 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Exalenz Bioscience Ltd, Key Facts
Exalenz Bioscience Ltd, Key Employees
Exalenz Bioscience Ltd, Key Employee Biographies
Exalenz Bioscience Ltd, Major Products and Services
Exalenz Bioscience Ltd, History
Exalenz Bioscience Ltd, Subsidiaries
Exalenz Bioscience Ltd, Key Competitors
Exalenz Bioscience Ltd, Ratios based on current share price
Exalenz Bioscience Ltd, Annual Ratios
Exalenz Bioscience Ltd, Annual Ratios (Cont...1)
Exalenz Bioscience Ltd, Interim Ratios
Exalenz Bioscience Ltd, Medical Equipment, Deals By Year, 2014 to YTD 2020
Exalenz Bioscience Ltd, Medical Equipment, Deals By Type, 2014 to YTD 2020
Exalenz Bioscience Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Exalenz Bioscience Ltd, Performance Chart (2015 - 2019)
Exalenz Bioscience Ltd, Ratio Charts
Exalenz Bioscience Ltd, Medical Equipment, Deals By Year, 2014 to YTD 2020
Exalenz Bioscience Ltd, Medical Equipment, Deals by Type, 2014 to YTD 2020

COMPANIES MENTIONED

Serim Research Corporation
Meridian Bioscience Inc
MedMira Inc
Kibion AB